
- /
- Supported exchanges
- / US
- / SGHT.NASDAQ
Sight Sciences Inc (SGHT NASDAQ) stock market data APIs
Sight Sciences Inc Financial Data Overview
Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases. The company operates in two segments, Surgical Glaucoma and Dry Eye. Its products include OMNI surgical system, an implant-free, handheld, single-use, therapeutic technology that enables ophthalmic surgeons to perform a comprehensive procedure indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma, as well as for the catheterization and transluminal viscodilation of Schlemm's canal and cutting of the trabecular meshwork to reduce intraocular pressure in adult patients with open-angle glaucoma; and SION surgical instrument, a bladeless manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The company also provides TearCare system, a dry eye device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Sight Sciences Inc data using free add-ons & libraries
Get Sight Sciences Inc Fundamental Data
Sight Sciences Inc Fundamental data includes:
- Net Revenue: 78 109 K
- EBITDA: -48 999 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-04-30
- EPS/Forecast: -0.28
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Sight Sciences Inc News

Sight Sciences CLO Hayden sells $38k in SGHT stock
Sight Sciences , Inc. (NASDAQ:SGHT) Chief Legal Officer Jeremy B. Hayden, disposed of 9,160 shares of common stock on July 3, 2025. The shares were sold at a price of $4.174, for a total transaction v...


Sight Sciences Leads The Pack Of 3 Promising Penny Stocks
The United States market has remained flat over the past week but is up 11% over the past year, with earnings projected to grow by 15% annually. Though the term 'penny stock' might sound like a relic ...

Insider Purchase: Director at $SGHT Buys 25,230 Shares
Staffan Encrantz, a director at $SGHT, bought 25,230 shares of the company on 06-03-2025 for an estimated $100,087. This trade was reported by Quiver Quantitative using data from a recent SEC filing. ...

Sight Sciences to Report First Quarter 2025 Financial Results on May 8, 2025
MENLO PARK, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commer...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.